While we can never know for sure, it is pretty encouraging that estimates for SURG have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. On Dec 10, the company reported better-than-expected fiscal first quarter earnings per share. Plus, the stock actually has a Zacks Rank #1 (Strong Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment